The DNA damage checkpoint protein ATM promotes hepatocellular apoptosis and fibrosis in a mouse model of non-alcoholic fatty liver disease.
about
Management of Hepatocellular Carcinoma in Cirrhotic Patients with Portal Hypertension: Relevance of Hagen-Poiseuille's LawPDE5 inhibitors enhance the lethality of standard of care chemotherapy in pediatric CNS tumor cells.CCR2 and CD44 promote inflammatory cell recruitment during fatty liver formation in a lithogenic diet fed mouse model.Fluoride Intensifies Hypercaloric Diet-Induced ER Oxidative Stress and Alters Lipid Metabolism.Non-alcoholic fatty liver disease induces signs of Alzheimer's disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD modelProteomic profiling of cellular steatosis with concomitant oxidative stress in vitroThe p53 Codon 72 Polymorphism Modifies the Cellular Response to Inflammatory Challenge in the LiverAnalysis of Therapeutic Effect of Ilex hainanensis Merr. Extract on Nonalcoholic Fatty Liver Disease through Urine Metabolite Profiling by Ultraperformance Liquid Chromatography/Quadrupole Time of Flight Mass Spectrometry.ATM kinase activity modulates ITCH E3-ubiquitin ligase activity.Protective effects of various ratios of DHA/EPA supplementation on high-fat diet-induced liver damage in mice.Epigenetics in radiation-induced fibrosis.Hagen-Poiseuille's law: The link between cirrhosis, liver stiffness, portal hypertension and hepatic decompensation.DNA damage response and sphingolipid signaling in liver diseases.The role of iNOS in cholesterol-induced liver fibrosis.Frequently mutated genes/pathways and genomic instability as prevention targets in liver cancer.Is age a risk factor for liver disease and metabolic alterations in ataxia Telangiectasia patients?Metabonomic analysis of the therapeutic effect of Potentilla discolor in the treatment of type 2 diabetes mellitus.Mildly compromised tetrahydrobiopterin cofactor biosynthesis due to Pts variants leads to unusual body fat distribution and abdominal obesity in mice.Apoptosis and non-alcoholic fatty liver diseases.
P2860
Q26797581-42E647A6-AE88-424E-84F4-32817DC0DD69Q33727865-97A475F8-95C0-49DB-BF93-B61620B729FEQ34769732-5FBF1C69-53B2-48BC-8954-7334B744E4D3Q36059903-D9011EF6-48B4-4E5F-883C-0B876C6EAEB2Q36428502-98E8554B-A14C-4D55-B67A-E71DB048EEECQ37059528-53F72181-2D04-4E2A-9D3E-D7C869141E63Q37120247-6E6AC82F-28B3-442A-8E07-73C3675D1CBEQ37166645-8D8DEAA3-65F6-4B53-97E2-1EEB2BDF01D0Q37609934-F5F48A6F-DFD7-4605-A9DA-8DF465456511Q37728636-E21ED3EE-8405-43F5-982E-FB168655E663Q38218535-73E732CF-D930-4939-A75F-C9EBCB17AB9BQ38334016-96ED355B-CDA3-4937-B7AE-98F34BD24EF1Q38619642-872E1E3F-0E3A-4D82-98B6-E05A8242F64AQ38861311-4E267A76-29E7-4C83-BEB1-6043C8446B7BQ39006737-0094F63F-0411-4278-AF65-4AAB6271D158Q41263470-EFAAE6A8-45E2-4660-9886-B61FDBA6F9CBQ42202080-C0AC0CEA-5683-452A-8001-6E4E9905C9E0Q48938000-F37BB457-F690-407F-87C7-A5DE87AB94E2Q55503094-C89AC73D-A087-44F1-9284-769E2D9BDA62
P2860
The DNA damage checkpoint protein ATM promotes hepatocellular apoptosis and fibrosis in a mouse model of non-alcoholic fatty liver disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The DNA damage checkpoint prot ...... alcoholic fatty liver disease.
@ast
The DNA damage checkpoint prot ...... alcoholic fatty liver disease.
@en
type
label
The DNA damage checkpoint prot ...... alcoholic fatty liver disease.
@ast
The DNA damage checkpoint prot ...... alcoholic fatty liver disease.
@en
prefLabel
The DNA damage checkpoint prot ...... alcoholic fatty liver disease.
@ast
The DNA damage checkpoint prot ...... alcoholic fatty liver disease.
@en
P2093
P2860
P356
P1433
P1476
The DNA damage checkpoint prot ...... alcoholic fatty liver disease.
@en
P2093
Ahmed Al Saei
Arlin B Rogers
Delbert Abi Abdallah
Elizabeth S Moore
Erin K Daugherity
Gabriel Balmus
Kirk J Maurer
Robert S Weiss
P2860
P304
P356
10.4161/CC.20259
P577
2012-05-15T00:00:00Z